Hopes for resolution on trade between US and China boost markets

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The FTSE 100 gathered momentum by midday, up 1.3% to 7,519.08, as futures markets pointed to a higher open on Wall Street.

This followed Donald Trump's apparently constructive meeting on trade with Chinese counterpart Xi Jinping at the G20 summit over the weekend.

Amid a sea of green, China-related stocks were particularly in favour with JPMorgan Chinese Investment Trust up 7.7%.

LARGE AND MID CAP RISERS AND FALLERS

Publishing firm Future was up 7.7% as it guided for results for the year to 30 September to be ahead of expectations.

Advertising group WPP rose 2.2% after it announced that it had sold its minority shareholding in sports, entertainment and communications group Chime Group Holdings to majority shareholder Providence for £54.4m.

Fresnillo dropped 3.9% on revealing that it expected profits to take an $8m hit, owing to a reassessment of an historical Mexican tax burden.

AstraZeneca advanced 1.2% after the pharmaceutical company said that European regulators had delivered a positive opinion on the cardiovascular outcomes of its type-2 diabetes treatment.

Packaging company DS Smith firmed 1.8% as it completed the sale of two packaging businesses in France and Portugal to International Paper for €63m (£56m).

SMALL CAP RISERS AND FALLERS

Consulting company Science Group shed 0.3% after it made a firm takeover bid for digital radio company Frontier Smart Technologies at 35p per share. Frontier shares jumped 12% to 36.4p amid hopes of a bidding war.

E-sports company Gfinty rallied 1% on announcing that it expected its annual performance to be 'slightly' better than market expectations, as growth in strategic partnerships helped bolster revenues and earnings.

Recruitment firm SThree gained 1.0%, despite announcing that chief operating officer Justin Hughes was standing down from 1 July.

Healthcare group Alliance Pharma dipped 2.5% after it announced that its founder and chief executive John Dawson was standing down.

Engineering group Ricardo fell 1.8% on news that it had agreed to shell out A$9.6m (£5.4m) acquiring Melbourne-based environment, planning and infrastructure advisory consultancy PLC Consulting.